Kinetics of Perioperative Circulating DNA in Cancer Surgery
NCT ID: NCT03284684
Last Updated: 2025-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2018-01-22
2018-11-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anemia and Red Blood Cells Transfusion in Oncological Surgery
NCT04101240
Perioperative Care in the Cancer Patient -1, ARCA-1 Study
NCT04491409
Perioperative Risk Study
NCT02456389
Post-operative Monitoring of Gastric Cancer
NCT07026240
To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal Cancer
NCT05606848
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
circulating DNA plasma level test
Blood test
plasma concentration of circulating DNA of specific genes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood test
plasma concentration of circulating DNA of specific genes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be a member or beneficiary of a health insurance plan
* The patient is aged between 18-75
* Patient must weigh \>40kg
* The patient will receive adjusted carcinological surgery
* Indication of curative surgery
* The patient has already undergone tumoral biopsy prior to surgery
* The patient has stage M0 cancer of either colon (right or left colonic adenocarcinoma), prostate (adenocarcinoma) or breast (infiltrating carcinoma)
Exclusion Criteria
* The patient is under safeguard of justice
* The subject refuses to sign the consent
* It is impossible to give the subject informed information
* The patient is pregnant, parturient or breast feeding
* Chronic alcoholism
* The patient has received radiotherapy or chemotherapy periopratively
* Cancer other than colon, breast or prostate
* The patient has currently or in the past, had a cancerous lesion
* Neo-adjuvant therapy (immunotherapy, radiotherapy, chemotherapy)
* Emergency cancer surgery
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Montpellier
Montpellier, , France
Institut de Cancérologie Montpellier
Montpellier, , France
CHU Nimes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kudriavtsev A, Pastor B, Mirandola A, Pisareva E, Gricourt Y, Capdevila X, Thierry AR, Cuvillon P. Association of the immediate perioperative dynamics of circulating DNA levels and neutrophil extracellular traps formation in cancer patients. Precis Clin Med. 2024 Mar 27;7(2):pbae008. doi: 10.1093/pcmedi/pbae008. eCollection 2024 Jun.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A00950-53
Identifier Type: OTHER
Identifier Source: secondary_id
NIMAO/2016/PC-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.